RTI SURGICAL, INC. (NASDAQ:RTIX) Files An 8-K Regulation FD Disclosure

RTI SURGICAL, INC. (NASDAQ:RTIX) Files An 8-K Regulation FD Disclosure
Item 7.01

Story continues below

EX-99.1 2 d682926dex991.htm EX-99.1 EX-99.1 Press Release      RTI Surgical® Completes Acquisition of Paradigm Spine Company Integrates coflex ® Interlaminar Stabilization ® Device into Growing Spine Portfolio Further Advances RTI’s Strategic Transformation Focused on Spine and OEM DEERFIELD,…
To view the full exhibit click here


RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons. The Company distributes its implants and services in approximately 50 states and in over 45 countries across the world.

An ad to help with our costs